Etopophos (Etoposide phosphate Vials) 100mg/5ml

Etopophos (etoposide phosphate) is a chemotherapy medication used for cancer treatment. It comes in vials of 100mg/5ml for intravenous use. This Australian-made injectable targets rapidly dividing cells. Suitable for patients seeking chemotherapy options.

Strength

100mg/5ml

Pack Size

Manufacturer / TM Owner

Pftizer Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Etoposide phosphate is primarily used to treat certain types of cancer, including lung cancer, testicular cancer, and lymphoma. It may also be used in combination therapies for other malignancies. The medication works by slowing or stopping cancer cell growth. Patients often ask, 'what is etoposide phosphate used for' when discussing treatment options.

Side Effects

Etoposide phosphate may cause side effects such as nausea, vomiting, or fatigue. Hair loss is a possible effect due to its impact on rapidly dividing cells. Some patients report changes in blood cell counts, which can increase infection risk. These effects vary by individual and treatment duration.

Precautions & Warnings

Etoposide phosphate should be handled with care by healthcare professionals. Avoid direct contact with skin or mucous membranes. Pregnant individuals should discuss risks with their doctor before use. Patients must follow medical guidance for administration and monitoring.

Avoid Interactions

Etoposide phosphate may interact with other medications, including blood thinners and certain antibiotics. Alcohol and vaccines should be avoided during treatment. CYP3A4 inhibitors may affect its metabolism. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

Etoposide phosphate is used to treat certain cancers, including lung cancer, testicular cancer, and lymphoma.

It is given as an intravenous injection by healthcare professionals in a clinical setting.

Common side effects include nausea, vomiting, fatigue, and hair loss.

Pregnant individuals should consult their doctor, as etoposide phosphate may harm an unborn baby.

Yes, it may interact with blood thinners, antibiotics, and CYP3A4 inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.